β-blocker use in patients after percutaneous coronary interventions: One size fits all? Worse outcomes in patients without myocardial infarction or heart failure-Reference-Cited by-同舟云学术

β-blocker use in patients after percutaneous coronary interventions: One size fits all? Worse outcomes in patients without myocardial infarction or heart failure

Published:2013-09 Issue:2 Volume:168 Page:774-779
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Ozasa Neiko,Morimoto Takeshi,Bao Bingyuan,Furukawa Yutaka,Nakagawa Yoshihisa,Kadota Kazushige,Iwabuchi Masashi,Shizuta Satoshi,Shiomi Hiroki,Tazaki Junichi,Natsuaki Masahiro,Kimura Takeshi

Funder

Pharmaceuticals and Medical Devices Agency (PMDA) in Japan

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. 2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina

2. Effect of β-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure;Bunch;Am J Cardiol,2005

3. Multifactorial actions of β-adrenergic blocking drugs in ischemic heart disease: current concepts;Frishman;Circulation,1983

4. Long-term safety and efficacy of sirolimus-eluting versus bare-metal stents in real world clinical practice in Japan;Kimura;Cardiovasc Interv Ther,2011

5. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease — the final analysis of the arterial revascularization therapies study (ARTS) randomized trial;Serruys;J Am Coll Cardiol,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beta Blockers in Contemporary Cardiology: Is It Better to Cast Them Out?;Korean Circulation Journal;2024

2. Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease;Journal of the American College of Cardiology;2023-06

3. Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention;Frontiers in Cardiovascular Medicine;2022-05-17

4. Role of β-Blockers in Chronic Coronary Artery Disease Management in the Percutaneous Coronary Intervention Era: Good Symptom Control or Something More?;Korean Circulation Journal;2022

5. Long‐term impact of β‐blocker in elderly patients without myocardial infarction after percutaneous coronary intervention;ESC Heart Failure;2021-11-22